within Pharmacolibrary.Drugs.ATC.R;

model R01BA52
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.006166666666666667,
    adminDuration  = 600,
    adminMass      = 0.06,
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005833333333333333,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Pseudoephedrine is a sympathomimetic amine commonly used as a nasal decongestant. It acts by stimulating alpha-adrenergic receptors, leading to vasoconstriction in the nasal mucosa, and is frequently included in combination with antihistamines or analgesics for symptomatic relief of cold, allergy, or sinus congestion. Pseudoephedrine-containing products remain approved and widely available, although some countries regulate their sale due to misuse in illicit synthesis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for pseudoephedrine in healthy adult volunteers after oral administration of pseudoephedrine-containing combination products.</p><h4>References</h4><ol><li>Shawn Flanagan, Sonia L Minassian, Philippe Prokocimer,Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers.,Journal of clinical medicine,2018<a href='https://pubmed.ncbi.nlm.nih.gov/29899212/'>https://pubmed.ncbi.nlm.nih.gov/29899212/</a></li><li>L Hendeles,Selecting a decongestant.,Pharmacotherapy,1993<a href='https://pubmed.ncbi.nlm.nih.gov/7507590/'>https://pubmed.ncbi.nlm.nih.gov/7507590/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R01BA52;
